Literature DB >> 30701465

JSH Practical Guidelines for Hematological Malignancies, 2018: II. Lymphoma-8. Adult T-cell leukemia-lymphoma.

Kunihiro Tsukasaki1, Takuya Fukushima2.   

Abstract

Entities:  

Mesh:

Year:  2019        PMID: 30701465     DOI: 10.1007/s12185-018-02588-5

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  5 in total

1.  GVHD-free, relapse-free survival provides novel clues for optimizing allogeneic-HSCT for adult T-cell leukemia/lymphoma.

Authors:  Hiroyuki Muranushi; Takero Shindo; Masakatsu Hishizawa; Masahito Tokunaga; Atsushi Wake; Nobuaki Nakano; Tetsuya Eto; Michihiro Hidaka; Ilseung Choi; Toshihiro Miyamoto; Naoyuki Uchida; Yukiyoshi Moriuchi; Yasuhiko Miyazaki; Takahiro Fukuda; Tatsuo Ichinohe; Yoshiko Atsuta; Koji Kato
Journal:  Bone Marrow Transplant       Date:  2020-07-14       Impact factor: 5.483

2.  CD4+ CADM1+ cell percentage predicts disease progression in HTLV-1 carriers and indolent adult T-cell leukemia/lymphoma.

Authors:  Junya Makiyama; Seiichiro Kobayashi; Eri Watanabe; Tomohiro Ishigaki; Toyotaka Kawamata; Makoto Nakashima; Makoto Yamagishi; Kazumi Nakano; Arinobu Tojo; Toshiki Watanabe; Kaoru Uchimaru
Journal:  Cancer Sci       Date:  2019-12       Impact factor: 6.716

Review 3.  Nationwide Hospital-Based Survey of Adult T-Cell Leukemia/Lymphoma in Japan.

Authors:  Takeharu Kato; Yoshitaka Imaizumi; Yasushi Miyazaki
Journal:  Viruses       Date:  2022-04-11       Impact factor: 5.048

4.  Oral histone deacetylase inhibitor tucidinostat (HBI-8000) in patients with relapsed or refractory adult T-cell leukemia/lymphoma: Phase IIb results.

Authors:  Atae Utsunomiya; Koji Izutsu; Tatsuro Jo; Shinichiro Yoshida; Kunihiro Tsukasaki; Kiyoshi Ando; Ilseung Choi; Yoshitaka Imaizumi; Koji Kato; Mitsutoshi Kurosawa; Shigeru Kusumoto; Takashi Miyagi; Eiichi Ohtsuka; Osamu Sasaki; Hirohiko Shibayama; Kazuya Shimoda; Yasushi Takamatsu; Kuniko Takano; Kentaro Yonekura; Shinichi Makita; Jun Taguchi; Mireille Gillings; Hiroshi Onogi; Kensei Tobinai
Journal:  Cancer Sci       Date:  2022-06-07       Impact factor: 6.518

5.  Improved survival of patients with aggressive ATL by increased use of allo-HCT: a prospective observational study.

Authors:  Ayumu Ito; Nobuaki Nakano; Takashi Tanaka; Shigeo Fuji; Junya Makiyama; Yoshitaka Inoue; Ilseung Choi; Hirohisa Nakamae; Koji Nagafuji; Ken Takase; Shinichiro Machida; Tsutomu Takahashi; Yasushi Sawayama; Tomohiko Kamimura; Koji Kato; Toshiro Kawakita; Masao Ogata; Rika Sakai; Souichi Shiratori; Kaoru Uchimaru; Yoshihiro Inamoto; Atae Utsunomiya; Takahiro Fukuda
Journal:  Blood Adv       Date:  2021-10-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.